Correction: Novel engineered IL-2 Nemvaleukin alfa combined with PD1 checkpoint blockade enhances the systemic anti-tumor responses of radiation therapy

Affiliations

• ¹ Department of Radiation Oncology, Shandong First Medical University and Shandong Academy of Medical Sciences, Shandong Cancer Hospital and Institute, Jinan, Shandong, China. hekewen9144@foxmail.com.
• ² Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. hekewen9144@foxmail.com.
• ³ Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
• ⁴ Department of Radiation Oncology, Koç University School of Medicine, Istanbul, Turkey.
• ⁵ Mural Oncology PLC, Waltham, MA, USA.
• ⁶ Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. jwelsh@mdanderson.org.